Hims & Hers Health Inc header image

Hims & Hers Health Inc

HIMS

Equity

ISIN US4330001060 / Valor 59397181

New York Stock Exchange, Inc (2024-09-18)
USD 16.31+1.30%

Hims & Hers Health Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Hims & Hers Health Inc. operates as a telehealth company that provides a broad range of health and wellness services through a fully online platform. The company, which boasts over 1 million subscribers, facilitates access to licensed healthcare professionals across all 50 states, including physicians, nurse practitioners, psychiatrists, dermatologists, and pharmacists. These professionals offer evidence-based treatment and care in various domains such as sexual health, skincare, mental health, and hair care. By leveraging technology, Hims & Hers Health Inc. aims to streamline the healthcare process, making it more accessible and convenient for patients to receive care. The company's model represents a shift towards more digital, patient-centered healthcare solutions, addressing key wellness areas through its online services.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Revenue Growth

Hims & Hers Health Inc. reported a significant increase in revenue for the first quarter of 2024. The company achieved a year-over-year revenue growth of 88%, reaching $190.8 million, which surpassed market expectations.

Net Income

In the first quarter of 2024, Hims & Hers Health Inc. reported a net income of $5.2 million. This marks a substantial improvement compared to the net loss of $8.9 million in the same quarter of the previous year.

Gross Margin

Hims & Hers Health Inc. achieved a gross margin of 77% in the first quarter of 2024. This represents a slight increase from the 75% gross margin reported in the first quarter of 2023, indicating improved operational efficiency.

Full-Year Guidance

Following the strong performance in the first quarter of 2024, Hims & Hers Health Inc. has raised its full-year revenue guidance. The company now expects to achieve total revenue in the range of $750 million to $770 million for the fiscal year 2024.

Customer Growth

Hims & Hers Health Inc. reported a 60% increase in the number of active subscribers in the first quarter of 2024. The company now serves over 1.2 million subscribers, reflecting the growing demand for its telehealth and wellness services.

Summarized from source with an LLMView Source

Key figures

157%1Y
86.8%3Y
%5Y

Performance

68.6%1Y
66.5%3Y
72.5%5Y

Volatility

Market cap

3394 M

Market cap (USD)

Daily traded volume (Shares)

1,266,872

Daily traded volume (Shares)

1 day high/low

16.8 / 16.15

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Shionogi Seiyaku KK
Shionogi Seiyaku KK Shionogi Seiyaku KK Valor: 763280
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.82%JPY 6,303.00
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.95%CHF 417.50
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.65%CHF 122.40
COLTENE HOLDING AG
COLTENE HOLDING AG COLTENE HOLDING AG Valor: 2534325
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.65%CHF 47.60
Insulet Corp
Insulet Corp Insulet Corp Valor: 2941247
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.24%USD 236.11
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.35%USD 57.70
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.89%USD 6.05
EssilorLuxottica SA
EssilorLuxottica SA EssilorLuxottica SA Valor: 497537
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.34%EUR 204.80
Eurofins Scientific SE
Eurofins Scientific SE Eurofins Scientific SE Valor: 58317129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.91%EUR 52.34
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%EUR 35.10